next generation egfr inhibitors for mutations and disease
Published 6 years ago • 215 plays • Length 27:37Download video MP4
Download video MP3
Similar videos
-
58:47
15 years of advances in egfr mutant lung cancer
-
1:32
dr. hirsch discusses the role of next-generation egfr inhibitors
-
24:58
strategies to prevent and overcome resistance to egfr-directed therapies in lung cancer
-
3:40
next-generation egfr inhibitors in patients with non-t790m resistance
-
44:45
yale cancer center grand rounds/john murren lecture
-
6:37
impressive findings for next-generation egfr inhibitors
-
24:42
mechanisms of lung tumorigenesis by mutant egfr
-
6:14
third-generation egfr inhibitors in nsclc
-
21:41
beyond erlotinib: are second generation egfr inhibitors better or simply newer?
-
39:35
egfr mutation analysis
-
18:06
egfr inhibitors in mutation ( ) patients: current therapeutic strategies in the frontline setting
-
55:38
novel therapy for lung cancer: from targeted therapy to immuno-therapy and back again!
-
4:25
how to understand egfr t790m mutations | dana-farber cancer institute
-
8:30
third-generation egfr inhibitors in nsclc
-
3:15
does the specific egfr mutation matter when choosing an oral egfr inhibitor?
-
49:55
yale cancer center grand rounds | june 8, 2021
-
3:15
how do we make egfr inhibitors work better for patients
-
1:02:40
new milestones and changing standards of care in early egfr-mutated nsclc
-
39:00
image guided targeted biopsy and its impact on next generation cancer care